Michael R. Stabley

Array ( [id] => 4406122 [patent_doc_number] => 06238889 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Molecular cloning and expression of the Pro8 isoform of human IL-3' [patent_app_type] => 1 [patent_app_number] => 8/470369 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 35 [patent_no_of_words] => 18185 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238889.pdf [firstpage_image] =>[orig_patent_app_number] => 470369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697099 [patent_doc_number] => 05674494 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Treating non-malignant disease states with IL-2 receptor-specific substances' [patent_app_type] => 1 [patent_app_number] => 8/485554 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3930 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674494.pdf [firstpage_image] =>[orig_patent_app_number] => 485554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3551483 [patent_doc_number] => 05543141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Therapeutic methods using interleukin-3 (IL-3) human/murine hybrid polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/466647 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 27583 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543141.pdf [firstpage_image] =>[orig_patent_app_number] => 466647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725840 [patent_doc_number] => 05670335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Mammalian inward rectifier potasssium channel cDNAs, host cells expressing them, and screening assays using such cells' [patent_app_type] => 1 [patent_app_number] => 8/461690 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 40 [patent_no_of_words] => 18797 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670335.pdf [firstpage_image] =>[orig_patent_app_number] => 461690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3885513 [patent_doc_number] => 05714382 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Synthetic plasmids and transformants comprising a feline interferon cDNA' [patent_app_type] => 1 [patent_app_number] => 8/463242 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6452 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714382.pdf [firstpage_image] =>[orig_patent_app_number] => 463242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848178 [patent_doc_number] => 05719120 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-17 [patent_title] => 'Use of endoglin polypeptides for modifying the regulatory activity of TGF-.beta.' [patent_app_type] => 1 [patent_app_number] => 8/459194 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 5400 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/719/05719120.pdf [firstpage_image] =>[orig_patent_app_number] => 459194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4029765 [patent_doc_number] => 05942223 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Antiviral therapy using ovine or bovine interferon-tau' [patent_app_type] => 1 [patent_app_number] => 8/455524 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 36375 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942223.pdf [firstpage_image] =>[orig_patent_app_number] => 455524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825102 [patent_doc_number] => 05738845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Human interferon .tau. proteins and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/443883 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 31134 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/738/05738845.pdf [firstpage_image] =>[orig_patent_app_number] => 443883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3975576 [patent_doc_number] => 05958402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Antitumor therapy using ovine or bovine interferon-tau' [patent_app_type] => 1 [patent_app_number] => 8/455021 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 36382 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958402.pdf [firstpage_image] =>[orig_patent_app_number] => 455021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3814620 [patent_doc_number] => 05770445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Glucagon receptor proteins, peptides, and antibodies' [patent_app_type] => 1 [patent_app_number] => 8/453956 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28359 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770445.pdf [firstpage_image] =>[orig_patent_app_number] => 453956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655396 [patent_doc_number] => 05622839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Recombinant production of human calcitonin receptor polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/453742 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 20038 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622839.pdf [firstpage_image] =>[orig_patent_app_number] => 453742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915156 [patent_doc_number] => 06001969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Recombinant TGF-.beta. type II receptor polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/451946 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15271 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001969.pdf [firstpage_image] =>[orig_patent_app_number] => 451946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085218 [patent_doc_number] => 06132987 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Recombinant mammalian monocyte chemotactic protein-1 (MCP-1) receptors (MCP-1R, CCR-2)' [patent_app_type] => 1 [patent_app_number] => 8/446669 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 22065 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132987.pdf [firstpage_image] =>[orig_patent_app_number] => 446669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4228020 [patent_doc_number] => 06117423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Highly purified species of human leukocyte interferon' [patent_app_type] => 1 [patent_app_number] => 8/452626 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 16837 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117423.pdf [firstpage_image] =>[orig_patent_app_number] => 452626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3810830 [patent_doc_number] => 05770191 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Active C-terminal peptides of interferon--gamma and their use' [patent_app_type] => 1 [patent_app_number] => 8/449639 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 5450 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770191.pdf [firstpage_image] =>[orig_patent_app_number] => 449639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038259 [patent_doc_number] => 05874077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Human til cells expressing recombinant TNF prohormone' [patent_app_type] => 1 [patent_app_number] => 8/448889 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 17655 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874077.pdf [firstpage_image] =>[orig_patent_app_number] => 448889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062646 [patent_doc_number] => 06008011 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'TGF-.beta. type II receptor cDNAs' [patent_app_type] => 1 [patent_app_number] => 8/446938 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 15273 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008011.pdf [firstpage_image] =>[orig_patent_app_number] => 446938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4114953 [patent_doc_number] => 06046157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Modulation of TGF-.beta. by recombinant TGF-.beta. type II receptor polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/446939 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14966 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046157.pdf [firstpage_image] =>[orig_patent_app_number] => 446939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3796103 [patent_doc_number] => 05827694 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/446171 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13965 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827694.pdf [firstpage_image] =>[orig_patent_app_number] => 446171 [rel_patent_id] =>[rel_patent_doc_number] =>)